Lone Star Bio
Filter News
Found 14,266 articles
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
ESO Publishes Peer-Reviewed Paper On Prehospital Ketamine Use At A National Level
6/11/2021
ESO today announced findings from a peer-reviewed research study focused on prehospital ketamine.
-
Orthofix Announces Participation in Upcoming JMP Securities Life Sciences Conference
6/11/2021
Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in a fireside chat during the upcoming JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 11:00 a.m. ET.
-
ReCode Therapeutics Presents Preclinical Data Using SORT-LNP™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS)
6/11/2021
ReCode Therapeutics Presents Preclinical Data Using SORT-LNP ™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS).
-
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics
6/11/2021
SWK Holdings Corporation today announced that its wholly-owned subsidiary, Enteris BioPharma, received a $10 million milestone payment from Cara Therapeutics.
-
FDAQRC Announces Staff Promotions and Hirings
6/10/2021
FDA Quality and Regulatory Consultants is pleased to announce the promotion of four employees. These promotions are a result of continued growth for the company.
-
Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event
6/10/2021
Online Event Scheduled for Monday, June 21, 2021 at 2:00 p.m., ET by Salarius Pharmaceuticals.
-
Taysha Gene Therapies to Host First Annual Stockholder Meeting
6/10/2021
The Annual Stockholder Meeting on June 17, 2021 at 10 am ET.
-
Plus Therapeutics Presents at the Sixth Biennial Pediatric Neuro-Oncology Research Conference
6/10/2021
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company, today announced it will present a poster at the 6th Biennial Pediatric Neuro-Oncology Research Conference hosted by the Society for Neuro-Oncology (SNO), being held virtually June 10-12, 2021.
-
Additional Data Presented at DDW® 2021 from a Phase 2 Clinical Trial of Intracystic NanoPac® for Mucinous Cystic Neoplasms of the Pancreas
6/9/2021
NanOlogy, LLC, a clinical-stage oncology company, announced that additional data from its Phase 2 dose-rising and expansion clinical trial of intracystic NanoPac® for mucinous cystic neoplasms of the pancreas were presented via poster by Somashekar Krishna, MD, MPH of The Ohio State University Wexner Medical Center and The James Comprehensive Cancer Center during Digestive Disease Week held virtually from May 21-23, 2021.
-
Texas Children's Hospital Center for Vaccine Development COVID-19 Subunit Vaccine Candidate Advancing Towards Global Access
6/9/2021
Texas Children's Hospital and Baylor College of Medicine leading COVID-19 subunit vaccine candidate, developed with Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company, has received approval to proceed with Phase III clinical trials in India.
-
Hummingbird Bioscience and Novogene enter into strategic partnership to expand precision medicine testing for individuals with NRG1-fusion driven cancers in China
6/9/2021
Partnership will enhance biomarker-driven patient enrollment in clinical trials of Hummingbird Bioscience's lead program, HMBD-001
-
U.S. Renal Care Completes Second Round of COVID-19 Vaccine Distribution
6/9/2021
U.S. Renal Care, a leading provider of dialysis services, announced it has completed administering the second round of mRNA vaccines to patients, ensuring better protection against the deadly coronavirus for thousands of vulnerable patients on dialysis.
-
DNAtrix to Present at the Raymond James Human Health Innovations Conference
6/9/2021
DNAtrix, today announced that the company will present at the Raymond James Human Health Innovations Conference on Monday, June 21, 2021 , at 1:20 pm ET .
-
Plus Therapeutics to Participate in BIO Digital Conference
6/9/2021
Plus Therapeutics, Inc. today announced that Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics, will participate in the BIO Digital Conference being held June 10-11 and 14-18, 2021.
-
Please check out the biopharma industry's COVID-19 stories that are trending for June 8, 2021.
-
DiFusion Technologies Announces New Board Member and Leadership
6/8/2021
DiFusion Technologies, maker of the ZFUZE™ suite of surgical polymers, today announced the addition of Todd Potokar to its Board of Directors.
-
New Study Finds ADHD Test Serves as a Better Indicator of Medication Effects
6/8/2021
A study published in the Journal of Clinical Psychopharmacology found that an FDA cleared, computer-based, objective measurement of attention-deficit/hyperactivity disorder (ADHD) symptoms was more sensitive to medication effects than patient self-rating, at both one-month and six-month follow-up visits
-
Foundation Medicine Launches FoundationOne®Tracker ctDNA Monitoring Assay for Research Use in Partnership with Natera
6/8/2021
Foundation Medicine, Inc. and Natera, Inc., announced the launch of the research use version of FoundationOne®Tracker, Foundation Medicine's personalized circulating tumor DNA monitoring assay.
-
Rapid Therapeutic Prepares to bring Sublingual Spray Products to Market
6/8/2021
Rapid Therapeutic Science Laboratories, Inc., an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced it is preparing to launch a marketing and sales campaign of its recently enhanced sublingual spray line.